Reappraisal of total body irradiation followed by bone marrow transplantation as a therapy for inflammatory bowel disease

Immunobiology

Volumn 218, Issue 3, 2013, Pages 317-324

  Godoi, Dannielle Fernandes ^a   Cardoso, Cristina Ribeiro ^a   Silva, Marcelo José Barbosa ^b   Ferraz, Denise Brufato ^a   Provinciatto, Pauline Rossetti ^a   Cunha, Fernando de Queiróz ^a   da Silva, João Santana ^a   Voltarelli, Júlio César ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

Author keywords

Bone marrow transplantation; Colitis; Inflammatory bowel disease; Mucosal immunity; Total body irradiation

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; FEMALE; GOBLET CELL; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY CELL; INTERMETHOD COMPARISON; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME; WEIGHT GAIN; WHOLE BODY RADIATION;

ANIMALS; BONE MARROW TRANSPLANTATION; COLITIS; COMBINED MODALITY THERAPY; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNOSUPPRESSION; INFLAMMATION MEDIATORS; INFLAMMATORY BOWEL DISEASES; MALE; MICE; MICE, INBRED BALB C; TRINITROBENZENESULFONIC ACID; WEIGHT GAIN; WHOLE-BODY IRRADIATION;

EID: 84873115555     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2012.05.012     Document Type: Article

References (49)

1. Akitake R., Nakase H., Tamaoki M., Ueno S., Mikami S., Chiba T. Modulation of Th1/Th2 balance by infliximab rescues postoperative occurrence of small-intestinal inflammation associated with ulcerative colitis. Dig. Dis. Sci. 2010, 55:1781-1784.
2. Akobeng A.K., Gardener E. Oral 5-aminosalicylic acid for maintenance of medically induced remission in Crohn's Disease. Cochrane Database Syst. Rev. 2005, CD003715.
3. Bailón E., Camuesco D., Nieto A., Concha A., Fernández de Arriba A., Román J., Ramis I., Merlos M., Zarzuelo A., Gálvez J., Comalada M. The intestinal anti-inflammatory effects of the novel agent UR-1505 in the TNBS model of rat colitis are mediated by T-lymphocyte inhibition. Biochem. Pharmacol. 2007, 74:1496-1506.
4. Bishop M.R. Potential use of hematopoietic stem cells after radiation injury. Stem Cells 1997, 15(Suppl 2):305-310.
5. Burt R.K., Craig R.M., Milanetti F., Quigley K., Gozdziak P., Bucha J., Testori A., Halverson A., Verda L., de Villiers W.J., Jovanovic B., Oyama Y. Autologous nonmyeloablative hematopoietic stem cell transplantation in patients with severe anti-TNF refractory Crohn disease: long-term follow-up. Blood 2010, 116:6123-6132.
6. Burt R.K., Traynor A., Oyama Y., Craig R. High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn disease. Blood 2003, 101:2064-2066.
7. Chiodini R.J., Van Kruiningen H.J., Thayer W.R., Merkal R.S., Coutu J.A. Possible role of mycobacteria in inflammatory bowel disease. I. An unclassified Mycobacterium species isolated from patients with Crohn's disease. Dig. Dis. Sci. 1984, 29:1073-1079.
8. Chow E.J., Simmons J.H., Roth C.L., Baker K.S., Hoffmeister P.A., Sanders J.E., Friedman D.L. Increased cardiometabolic traits in pediatric survivors of acute lymphoblastic leukemia treated with total body irradiation. Biol. Blood Marrow Transplant. 2010, 16:1674-1681.
9. Davidson N.J., Fort M.M., Muller W., Leach M.W., Rennick D.M. Chronic colitis in IL-10-/- mice: insufficient counter regulation of a Th1 response. Int. Rev. Immunol. 2000, 19:91-121.
10. Dieleman L.A., Palmen M.J., Akol H., Bloemena E., Pena A.S., Meuwissen S.G., Van Rees E.P. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin. Exp. Immunol. 1998, 114:385-391.
11. Ding Y., Rotta M., Graves S.S., Storer B.E., Peterson L.J., Sale G.E., Forough R., Zellmer E., Georges G.E., Sandmaier B.M., Kuhr C.S., Storb R. Delaying DLA-haploidentical hematopoietic cell transplantation after total body irradiation. Biol. Blood Marrow Transplant. 2009, 15:1244-1250.
12. Dublineau I., Morel E., Griffiths N.M. Characterization of altered absorptive and secretory functions in the rat colon after abdominal irradiation: comparison with the effects of total-body irradiation. Radiat. Res. 2002, 157:52-61.
13. Duerr R.H., Taylor K.D., Brant S.R., Rioux J.D., Silverberg M.S., Daly M.J., Steinhart A.H., Abraham C., Regueiro M., Griffiths A., Dassopoulos T., Bitton A., Yang H., Targan S., Datta L.W., Kistner E.O., Schumm L.P., Lee A.T., Gregersen P.K., Barmada M.M., Rotter J.I., Nicolae D.L., Cho J.H. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006, 314:1461-1463.
14. Egi H., Hayamizu K., Yoshimitsu M., Shimamoto F., Oishi K., Ohmori I., Okajima M., Asahara T. Regulation of T helper type-1 immunity in hapten-induced colitis by host pretreatment with granulocyte colony-stimulating factor. Cytokine 2003, 23:23-30.
15. Elson C.O., Cong Y., Weaver C.T., Schoeb T.R., McClanahan T.K., Fick R.B., Kastelein R.A. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. Gastroenterology 2007, 132:2359-2370.
16. Fidder H., Schnitzler F., Ferrante M., Noman M., Katsanos K., Segaert S., Henckaerts L., Van Assche G., Vermeire S., Rutgeerts P. Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study. Gut 2009, 58:501-508.
17. Franchimont D., Vermeire S., El Housni H., Pierik M., Van Steen K., Gustot T., Quertinmont E., Abramowicz M., Van Gossum A., Deviere J., Rutgeerts P. Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 2004, 53:987-992.
18. Fuss I.J., Becker C., Yang Z., Groden C., Hornung R.L., Heller F., Neurath M.F., Strober W., Mannon P.J. Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody. Inflamm. Bowel Dis. 2006, 12:9-15.
19. Garg S., Boerma M., Wang J., Fu Q., Loose D.S., Kumar K.S., Hauer-Jensen M. Influence of sublethal total-body irradiation on immune cell populations in the intestinal mucosa. Radiat. Res. 2010, 173:469-478.
20. Gocheva L.B. Nonmyeloablative conditioning regimens and bone marrow transplantation - some contemporary aspects. Folia Med. (Plovdiv) 2010, 52:12-17.
21. Godoi D.F., Cardoso C.R., Ferraz D.B., Provinciatto P.R., Cunha F.Q., Silva J.S., Voltarelli J.C. Hematopoietic SCT modulates gut inflammation in experimental inflammatory bowel disease. Bone Marrow Transplant. 2010, 45:1562-1571.
22. Gross-Bellard M., Oudet P., Chambon P. Isolation of high-molecular-weight DNA from mammalian cells. Eur. J. Biochem. 1973, 36:32-38.
23. Hirama T., Tanosaki S., Kandatsu S., Kuroiwa N., Kamada T., Tsuji H., Yamada S., Katoh H., Yamamoto N., Tsujii H., Suzuki G., Akashi M. Initial medical management of patients severely irradiated in the Tokai-mura criticality accident. Br. J. Radiol. 2003, 76:246-253.
24. Hommes D.W., Duijvestein M., Zelinkova Z., Stokkers P.C., Ley M.H., Stoker J., Voermans C., van Oers M.H., Kersten M.J. Long-term follow-up of autologous hematopoietic stem cell transplantation for severe refractory Crohn's disease. J. Crohns Colitis 2011, 5:543-549.
25. Hu K.X., Sun Q.Y., Guo M., Ai H.S. The radiation protection and therapy effects of mesenchymal stem cells in mice with acute radiation injury. Br. J. Radiol. 2010, 83:52-58.
26. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., Almer S., Tysk C., O'Morain C.A., Gassull M., Binder V., Finkel Y., Cortot A., Modigliani R., Laurent-Puig P., Gower-Rousseau C., Macry J., Colombel J.F., Sahbatou M., Thomas G. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001, 411:599-603.
27. Kamada N., Hisamatsu T., Okamoto S., Chinen H., Kobayashi T., Sato T., Sakuraba A., Kitazume M.T., Sugita A., Koganei K., Akagawa K.S., Hibi T. Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis. J. Clin. Invest. 2008, 118:2269-2280.
28. Kaminitz A., Mizrahi K., Yaniv I., Farkas D.L., Stein J., Askenasy N. Low levels of allogeneic but not syngeneic hematopoietic chimerism reverse autoimmune insulitis in prediabetic NOD mice. J. Autoimmun. 2009, 33:83-91.
29. Kojouharoff G., Hans W., Obermeier F., Mannel D.N., Andus T., Scholmerich J., Gross V., Falk W. Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice. Clin. Exp. Immunol. 1997, 107:353-358.
30. Komori M., Tsuji S., Tsujii M., Murata H., Iijima H., Yasumaru M., Nishida T., Irie T., Kawano S., Hori M. Involvement of bone marrow-derived cells in healing of experimental colitis in rats. Wound Repair Regen. 2005, 13:109-118.
31. Kozuch P.L., Hanauer S.B. Treatment of inflammatory bowel disease: a review of medical therapy. World J. Gastroenterol. 2008, 14:354-377.
32. Liang L., Dong C., Chen X., Fang Z., Xu J., Liu M., Zhang X., Gu D.S., Wang D., Du W., Zhu D., Han Z. Human umbilical cord mesenchymal stem cells ameliorate mice TNBS-induced colitis. Cell Transplant. 2011, 20:1395-1408.
33. Lim W.C., Hanauer S.B. Emerging biologic therapies in inflammatory bowel disease. Rev. Gastroenterol. Disord. 2004, 4:66-85.
34. Maloy K.J. The interleukin-23/interleukin-17 axis in intestinal inflammation. J. Intern. Med. 2008, 263:584-590.
35. Newman R., Cuan N., Hampartzoumian T., Connor S.J., Lloyd A.R., Grimm M.C. Vasoactive intestinal peptide impairs leucocyte migration but fails to modify experimental murine colitis. Clin. Exp. Immunol. 2005, 139:411-420.
36. Oyama Y., Craig R.M., Traynor A.E., Quigley K., Statkute L., Halverson A., Brush M., Verda L., Kowalska B., Krosnjar N., Kletzel M., Whitington P.F., Burt R.K. Autologous hematopoietic stem cell transplantation in patients with refractory Crohn's disease. Gastroenterology 2005, 128:552-563.
37. Richaud P.M., Soubeyran P., Eghbali H., Chacon B., Marit G., Broustet A., Hoerni B. Place of low-dose total body irradiation in the treatment of localized follicular non-Hodgkin's lymphoma: results of a pilot study. Int. J. Radiat. Oncol. Biol. Phys. 1998, 40:387-390.
38. Rutgeerts P., Geboes K., Vantrappen G., Beyls J., Kerremans R., Hiele M. Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990, 99:956-963.
39. Sandborn W.J., Feagan B.G., Fedorak R.N., Scherl E., Fleisher M.R., Katz S., Johanns J., Blank M., Rutgeerts P., Ustekinumab Crohn's Disease Study Group A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease. Gastroenterology 2008, 135:1130-1141.
40. Sartor R.B. Microbial-host interactions in inflammatory bowel diseases and experimental colitis. Nestle Nutr. Workshop Ser. Pediatr. Program. vol. 64 2009, 121-132.
41. Slonim A.E., Bulone L., Damore M.B., Goldberg T., Wingertzahn M.A., McKinley M.J. A preliminary study of growth hormone therapy for Crohn's disease. N. Engl. J. Med. 2000, 342:1633-1637.
42. Song D.Y., Lawrie W.T., Abrams R.A., Kafonek D.R., Bayless T.M., Welsh J.S., DeWeese T.L. Acute and late radiotherapy toxicity in patients with inflammatory bowel disease. Int. J. Radiat. Oncol. Biol. Phys. 2001, 51:455-459.
43. Srinivasan M., Summerlin D.J. Modulation of the colonic epithelial cell responses and amelioration of inflammation by CD80 blockade in TNBS colitis. Clin. Immunol. 2009, 133:411-421.
44. Strober W., Fuss I.J. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology 2011, 140:1756-1767.
45. Szczepanik M., Gryglewski A., Bryniarski K., Stachura J., Ptak W. Experimental inflammatory bowel disease - role of T cells. J. Physiol. Pharmacol. 2000, 51:333-346.
46. Tanaka H., Arimura Y., Yabana T., Goto A., Hosokawa M., Nagaishi K., Yamashita K., Yamamoto H., Sasaki Y., Fujimiya M., Imai K., Shinomura Y. Myogenic lineage differentiated mesenchymal stem cells enhance recovery from dextran sulfate sodium-induced colitis in the rat. J. Gastroenterol. 2010, 46:143-152.
47. Wang Y., Liu L., Pazhanisamy S.K., Li H., Meng A., Zhou D. Total body irradiation causes residual bone marrow injury by induction of persistent oxidative stress in murine hematopoietic stem cells. Free Radic. Biol. Med. 2010, 48:348-356.
48. Weissman I.L. The road ended up at stem cells. Immunol. Rev. 2002, 185:159-174.
49. Wong M., Ziring D., Korin Y., Desai S., Kim S., Lin J., Gjertson D., Braun J., Reed E., Singh R.R. TNFalpha blockade in human diseases: mechanisms and future directions. Clin. Immunol. 2008, 126:121-136.